Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Not Yet Recruiting

A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma

NCT07583771

Conditions: Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +21 more
Locations: Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Not Yet Recruiting

Autologous Versus Allogeneic Hematopoietic Stem Cell Transplantation for T-Lymphoblastic Leukemia/Lymphoma in First Complete Remission

NCT07577531

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT07582159

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, +16 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope at Irvine Lennar Irvine, California, United States

View Trial Details

Not Yet Recruiting

Golcadomide in Combination With Rituximab for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma

NCT07578077

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Not Yet Recruiting

Comparison of Serratus Posterior Superior Intercostal Plane Block and Deep Serratus Anterior Plane Block After Video-Assisted Thoracoscopic Surgery

NCT07553195

Conditions: Deep Serratus Anterior Plane Block, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Antalya City Hospital Antalya, Turkey (Türkiye)

View Trial Details

Not Yet Recruiting

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

NCT07576725

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +119 more
Locations: Uganda Cancer Institute Kampala, Uganda

View Trial Details

Not Yet Recruiting

Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma

NCT07569757

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: The First Affiliated Hospital of Bengbu Medical University Bengbu, Anhui, China

The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China

Beijing Chao-Yang Hospital,Capital Medical University Beijing, Beijing Municipality, China

Beijing Jishuitan Hospital,Capital Medical University Beijing, Beijing Municipality, China

View all 49 locations

View Trial Details

Not Yet Recruiting

Sotagliflozin as Prevention of Anthracycline-Related Cardiotoxicity

NCT07572175

Conditions: Anthracycline-induced Cardiotoxicity, Cardiotoxicity, Cardiovascular Diseases, +18 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Not Yet Recruiting

Emapalumab Prophylaxis of Bispecific T-Cell Engagers (BiTEs) Associated CRS and ICANS

NCT07567014

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: NYU Langone Health Perlmutter Cancer Center - Sunset Park Brooklyn, New York, United States

NYU Langone Health Perlmutter Cancer Center - Manhattan Manhattan, New York, United States

NYU Langone Health - Long Island Mineola, New York, United States

View Trial Details

Not Yet Recruiting

Frontline Risk-Adapted Optimization of Novel Targeted Immunotherapy Evaluation in High-Risk MCL

NCT07569965

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions